Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-427-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 8 February 2010 - 22 March 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with minor deviations, which had no impact on the integrity of the study.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- Temporary deviations from the minimum level of relative humidity occurred.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- Temporary deviations from the minimum level of relative humidity occurred.
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- Temporary deviations from the minimum level of relative humidity occurred.
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source:Charles River France, L’Arbresle Cedex, France.
- Age at study initiation: Young adult animals (approx. 9 weeks old)
- Weight at study initiation: Body weight variation was within +/- 20% of the sex mean.
- Housing: Macrolon cages (MIII type; height 18 cm).
- Diet (e.g. ad libitum): Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany).
- Water (e.g. ad libitum): Free access to tap water.
- Acclimation period: at least 5 days before the start of treatment under laboratory conditions
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.0 ± 3. 0ºC (actual range: 18.5 -22. 7ºC)
- Humidity (%): 40-70% (actual range: 39 - 65%)
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12 hours artificial fluorescent light and 12 hours darkness per day. - Vehicle:
- dimethylformamide
- Concentration:
- 0%, 10%, 25% and 50%
- No. of animals per dose:
- 5 animals per group
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility:
- Irritation:
- Lymph node proliferation response:
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method:
- Criteria used to consider a positive response: DPM values are presented for each animal and for each dose group. A Stimulation Index (SI) is calculated for each group. The SI is the ratio of the DPM/group compared to DPM/vehicle control group.
If the results indicate a SI ≥ 3, the test substance may be regarded as a skin sensitizer, based on the test guideline and recommendations done by ICCVAM (Reference 1). The results were evaluated according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) of the United Nations (2007) and the Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labeling and packaging of substances and mixtures. The EC3 value (the estimated test substance concentration that will give a SI =3) was determined, using linear interpolation
TREATMENT PREPARATION AND ADMINISTRATION:
Grading Irritation Reactions:
Erythema and eschar formation:
No erythema ..............................................................................……………………………………….. ......... 0
Slight erythema (barely perceptible) ....................................................……………………………… ............ 1
Well-defined erythema ...................................................................…………………………………… ........... 2
Severe erythema (beef redness) to slight eschar formation (injuries in depth) .........……………… ............ 3
Oedema formation:
No oedema .................................................................................……………………….……………… ......... 0
Slight oedema (barely perceptible) ......................................................……………………………… ............ 1
Moderate oedema....................................…………………… ....................................................................... 2
Severe oedema… ....................................................................................................................................... 3 - Positive control substance(s):
- other: dimethyl formamide
- Statistics:
- see below
- Positive control results:
- See Table 1 below.
- Parameter:
- SI
- Value:
- 1.7
- Test group / Remarks:
- Low dose - 10% concentration
- Parameter:
- SI
- Value:
- 2.6
- Test group / Remarks:
- Mid dose - 25% concentration
- Parameter:
- SI
- Value:
- 4.7
- Test group / Remarks:
- High dose - 50% concentration
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- Assessment of Contact Hypersensitivity to Modified Small Vinyl Ester was tested in the murine local lymph node assay (LLN A) in accordance the guidelines (OECD 429). The results showed that Modified Small Vinyl Ester elicited a SI> or equal to 3. The data showed a dose-response and an EC3 value of 29.8% was calculated. Thus, Modified Small Vinyl Ester was sensitizing in the murine local lymph node assay.
- Executive summary:
Assessment of Contact Hypersensitivity to Modified Small Vinyl Ester in the Mouse (Local Lymph Node Assay). The study was carried out in accordance with the guidelines (e.g. OECD 429). The concentrations of Modified Small Vinyl Ester selected for the main study were based on the results of a preliminary study. In the main study, three experimental groups of five female CBA/J mice were treated with test substance concentrations of 10, 25 or 50% w/w on three consecutive days, by open application on the ears. Five vehicle control animals were similarly treated, but with vehicle alone (N,N-dimethylformamide). Three days after the last exposure, all animals were injected with 3H-methylthymidine and five hours later the draining (auricular) lymph nodes were excised. After precipitation of the DNA of the lymph node cells, radioactivity measurements were performed. The activity was expressed as the number of disintegrations per minute (DPM) and a stimulation index (SI) was subsequently calculated for each group.
.
Slight irritation of the ears was shown by all animals treated at 10, 25% and 50%. The animals at the 25 and 50% dose groups showed also bald area on the head and ears. These skin reactions were considered not to have a toxicologically significant effect on the activity of the nodes. No oedema was observed in any of the animals examined. The auricular lymph nodes of most control animals and all animals at 10 and 25% were considered normal in size, except for one node of one control animal, which was increased in size. At the highest dose group the majority of animals showed increased size of the lymph nodes. No macroscopic abnormalities of the surrounding area were noted in any of the animals. Body weights and body weight gain of experimental animals remained in the same range as controls over the study period. The slight body weight loss, noted in some animals, was considered not toxicologically significant.
Mean DPM/animal values for the experimental groups treated with Modified Small Vinyl Ester concentrations 10, 25 and 50% were 481, 728 and 1329 DPM respectively. The mean DPM/animal value for the vehicle control group was 281 DPM. The SI values calculated for test concentrations 10, 25 and 50% were 1.7, 2.6 and 4.7, respectively. The results showed that Modified Small Vinyl Ester elicited a SI ≥ 3. The data showed dose-response and an EC3 value (the estimated test substance concentration that will give a SI =3) of 29.8% was calculated. Based on these results, Modified Small Vinyl Ester was sensitizing in the muirne local lymph node assay.
Reference
Table 1: Skin reactions, body weights and relative size auricular lymph nodes
Group |
test substance1 (% w/w) |
an2 |
Day 1 |
Day 3 Skin reactions dorsal surface ear |
Day 6 |
|||||
bw |
left |
right |
bw |
size nodes4 |
||||||
(g)3 |
erythema |
oedema |
erythema |
oedema |
(g)3 |
Left |
right |
|||
1 |
0% vehicle |
1 |
19 |
0 |
0 |
0 |
0 |
20 |
n |
n |
2 |
20 |
0 |
0 |
0 |
0 |
19 |
n |
n |
||
3 |
19 |
0 |
0 |
0 |
0 |
20 |
n |
n |
||
4 |
18 |
0 |
0 |
0 |
0 |
18 |
+ |
n |
||
5 |
18 |
0 |
0 |
0 |
0 |
18 |
n |
n |
||
2 |
10% |
6 |
20 |
1 |
0 |
1 |
0 |
18 |
n |
n |
7 |
18 |
1 |
0 |
1 |
0 |
18 |
n |
n |
||
8 |
18 |
1 |
0 |
1 |
0 |
18 |
n |
n |
||
9 |
19 |
1 |
0 |
1 |
0 |
19 |
n |
n |
||
10 |
18 |
1 |
0 |
1 |
0 |
18 |
n |
n |
||
3 |
25% |
11 |
19 |
15 |
0 |
15 |
0 |
19 |
n |
n |
12 |
19 |
15 |
0 |
15 |
0 |
19 |
n |
n |
||
13 |
20 |
15 |
0 |
15 |
0 |
20 |
n |
n |
||
14 |
20 |
15 |
0 |
15 |
0 |
21 |
n |
n |
||
15 |
19 |
15 |
0 |
15 |
0 |
20 |
n |
n |
||
4 |
50% |
16 |
19 |
15 |
0 |
15 |
0 |
18 |
n |
+ |
17 |
19 |
15 |
0 |
15 |
0 |
19 |
n |
n |
||
18 |
21 |
15 |
0 |
15 |
0 |
22 |
+ |
+ |
||
19 |
21 |
15 |
0 |
15 |
0 |
20 |
n |
+ |
||
20 |
18 |
15 |
0 |
15 |
0 |
18 |
+ |
+ |
1Vehicle: N,N-dimethylformamide.
2Animal number.
3Body weight (grams).
4Relative size auricular lymph nodes (-, -- or ---: degree of reduction, +,++ or +++: degree of enlargement, n: considered to be normal).
5Bald area on head and ears.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
Modified Small Vinyl Ester was tested in a murine Local Lymph Node Assay. The study was carried out in accordance with the guidelines (e.g. OECD 429). The concentrations of Modified Small Vinyl Ester selected for the main study were based on the results of a preliminary study. In the main study, three experimental groups of five female CBA/J mice were treated with test substance concentrations of 10, 25 or 50% w/w on three consecutive days, by open application on the ears. Five vehicle control animals were similarly treated, but with vehicle alone (N,N-dimethylformamide). Three days after the last exposure, all animals were injected with 3H-methylthymidine and five hours later the draining (auricular) lymph nodes were excised. After precipitation of the DNA of the lymph node cells, radioactivity measurements were performed. The activity was expressed as the number of disintegrations per minute (DPM) and a stimulation index (SI) was subsequently calculated for each group. The SI values calculated for test concentrations 10, 25 and 50% were 1.7, 2.6 and 4.7, respectively. The results show that Modified Small Vinyl Ester elicited a SI ≥ 3. The data showed dose-response and an EC3 value (the estimated test substance concentration that will give a SI =3) of 29.8% was calculated. Based on these results, Modified Small Vinyl Ester was sensitizing in the murine local lymph node assay.
Assessment of Contact Hypersensitivity to Modified Small Vinyl Ester in the Albino Guinea Pig (Maximization Test) was tested in a guideline study (OECD 406). The validity of the test method was controlled with a concurrent study using alpha-hexylcinnamic aldehyde. Modified Small Vinyl Ester concentrations selected for the main study were based on the results of a preliminary study. In the main study, ten experimental animals were intradermally injected with a 10% concentration and epidermally exposed to a 100% concentration. Five control animals were similarly treated, but with vehicle alone (propylene glycol). Approximately 24 hours before the epidermal induction exposure all animals were treated with 10% SDS. Two weeks after the epidermal application all animals were challenged with a 100% Modified Small Vinyl Ester and the vehicle.The signs of necrosis seen in the control animals after the intradermal injection with vehicle only were consistent with the results in the preliminary irritation study after injection of propylene glycol. The reactions noted in the experimental and control animals after the epidermal induction exposure were considered to be enhanced by the SDS treatment. Skin reactions of grade 1 were observed in 5 experimental animals in response to the 100% Modified Small Vinyl Ester. No skin reactions were evident in the vehicle control animals. No mortality occurred and no symptoms of systemic toxicity were observed in the animals of the main study. Body weight and body weight gain of experimental animals remained in the same range as controls over the study period. The skin reactions observed in response to a 100% Modified Small Vinyl Ester in 5/10 experimental animals in the challenge phase were considered indicative of sensitization, based on the absence of any response in the control animals. These results indicate a sensitization rate of 50 per cent.
Migrated from Short description of key information:
In a murine Local lymph node assay (LLNA) Modified Small Vinyl Ester induced dose-related skin reactions in the challenge phase and elicited a stimulation index (SI) larger than 3. An EC3 value of 29.8% was calculated. Thus, Modified Small Vinyl Ester was sensitising in the LLNA. In a guinea pig maximisation test Modified Small Vinyl Ester induced a sensitization rate of 50% (5/10 animals) after challenge with 100% Modified Small Vinyl Ester. Thus, Modified Small Vinyl Ester was also sensitizing in the guinea pig maximisation test.
Justification for selection of skin sensitisation endpoint:
Study conducted using the more modern LLNA protocol
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Modified Small Vinyl Ester was sensititizing both in a murine local lymph node assay and in a Guinea Pig Maximization Test. On this basis the substance is classified for skin sensitisation (Skin sensitiser, category 1B).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
